Emily Sammons - Concepedia

Author

Emily Sammons

Also Known As

C Salviani, E L Sammons, E Sammons, E. Sammons, Emily L Sammons, Emily L. Sammons, Emily Sammons, Francisco Javier Rossello Lozano, S. Ng, Sarah Y A Ng

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Oxford University of Leicester University of Glasgow University Hospitals of Leicester NHS Trust Boehringer Ingelheim (Germany)

About

Emily Sammons is an author at University of Oxford specializing in medicine, covid-19, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1K
2	Public Health	1	1	82
3	Hospital Medicine	1	1	555
4	Neurology	1	1	82
5	Neuroscience	1	1	82

Emily Sammons

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, Natalie Staplin, KJ Mayne, The Lancet Diabetes & Endocrinology	2023	88
Influence of noninvasive peripheral arterial blood pressure measurements on assessment of dynamic cerebral autoregulation Emily Sammons, Nilesh J. Samani, Stephen M. Smith, Journal of Applied Physiology HypertensionPressure MeasurementFinapres DeviceBlood PressureCerebral Vascular Regulation	2007	82
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial Natalie Staplin, Richard Haynes, PK Judge, The Lancet Diabetes & Endocrinology	2023	74
Effect of Fenofibrate on Progression of Diabetic Retinopathy David Preiss, Jennifer Logue, Emily Sammons, NEJM Evidence	2024	63
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial Parminder K. Judge, Katherine R. Tuttle, Natalie Staplin, Nephrology Dialysis Transplantation	2024	35
Continuous estimates of dynamic cerebral autoregulation: influence of non-invasive arterial blood pressure measurements Ronney B. Panerai, Emily Sammons, Stephen M. Smith, Physiological Measurement	2008	31
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31

Page 1